| Foster, Jason C. (Oribiotech 202001– CEO) |
Chief Executive Officer (CEO) |
Ori Biotech (Oribiotech) (Group) |
United Kingdom (GB) |
| Foster, John (Owl Biomedical Inc 201404 President) |
President/Director/Head Business Group/Unit/Division |
Miltenyi Biotec (Group) |
United States (USA) |
| Fotev, Zisi (Cenix BioScience 200502 CBO) |
Chief Business Officer (CBO) |
Cenix BioScience (Group) |
Germany |
| Fotin-Mleczek, Mariola (CureVac 201710 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CureVac (Group) |
Germany |
| Foulger, Paul (EKF Diagnostics 201307– Interim Finance Director before Company Secretary) |
Chief Financial Officer (CFO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Fouquet, Gerhard (Univ Kiel 201201 President + Professor) |
President/Director/Head Business Group/Unit/Division |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
| Fournier, Jennifer (Waters 201902 Director Product Marketing Chemistry Group) |
Sales Manager / Marketing Manager |
Waters (Group) |
United States (USA) |
| Fowler, Sanna (Lonza 201809 Head PR Lonza Pharma & Biotech) |
Public Relations Manager / Investor Relations Manager |
Lonza (Group) |
Switzerland |
| Fowles, Richard (United Kingdom (govt) 201010 Category Manager at RCUK SSC Ltd) |
n. a. |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Foy, Shaun P. (CRISPR Therapeutics 201404 CFO + Co-Founder + ERS Genomics CEO + Co-Founder before Nomura Phase4) |
Chief Financial Officer (CFO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Foy, Teri (BMS 202112 SVP Research + Early Development, Immuno-Oncology + Cell Therapy) |
President/Director/Head Business Group/Unit/Division |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Frahm, Thomas (TRI Thinking Reseach Instruments 202205 Head of Sales + BusDev formerly Norgenta) |
Cluster Manager |
TRI Thinking Research Instruments GmbH |
Germany |
| Francis, Richard (Novartis 201404– Divison Head of Sandoz before Biogen Idec + Sanofi + Wyeth) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Francisco, Elodie Caroti (Hedera Dx 202209 Head of Marketing) |
Sales Manager / Marketing Manager |
Hedera Dx S.A. |
Switzerland |
| Franco, Nicholas (Actelion 201106 Chief Business Developm Officer before Axcan Pharma Paris before Novartis Pharma AG) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Francoise, Jacques (CSM Instruments –201311 General Manager) |
General Manager (management) |
Anton Paar (Group) |
Switzerland |
| Frank, Gert (Geratherm 201507 CEO) |
Chief Executive Officer (CEO) |
Geratherm (Group) |
Germany |
| Frank, Hans-Georg (AplaGen 200810 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
AplaGen GmbH |
Germany |
| Frank, Peter (ScanBalt 201105 General Sectretary) |
Administrative Officer (personnel) |
ScanBalt Network (Scanbalt MTÜ) |
Estonia |
| Franken, Sebastian (Univ Bonn 201101 IBMB Team Leader Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Frankenne, Günter (november 200611– ) |
n. a. |
November (Group) |
Germany |
| Franksson, Olof (HotSwap 201102 CEO) |
Chief Executive Officer (CEO) |
HotSwap (Group) |
Sweden |
| Frantsits, Werner (Sanochemia 201208 CEO) |
Chief Executive Officer (CEO) |
Sanochemia (Group) |
Austria |
| Franz, Christoph (Roche 201403– Board Chairman before Lufthansa CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Franz, Oliver (Eppendorf 200804 Executive Director Portfolio Management PCR + Automation) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Franzen, Jochen (Bruker Daltonik) |
Company Founder |
Bruker (Group) |
Germany |
| Frasch, Markus (AppliChem 200904 Managing Director) |
Managing Director |
Illinois Tool Works (ITW) (Group) |
Germany |
| Fraser, Paul D. (Univ London 201403 Professor at Royal Holloway and Bedford New College) |
Professor |
University of London |
United Kingdom (GB) |
| Frauendorf, Holm (Univ Göttingen 200910 Head Div Zentrale Analytik) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Göttingen (Georg August University) |
Germany |
| Frearson, Julie (Charles River 201711 Corp VP Global Discovery Services) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
| Frech, Kornelie (Genomatix 200608 Head of Biological Databases) |
n. a. |
Genomatix Software (Group) |
Germany |
| Fréchet, Jean M. J. (KAUST 201803 Prof + SVP Research + Innovation + Economic Development) |
Professor |
King Abdullah University of Science and Technology (KAUST) |
Saudi Arabia |
| Freedman, Stephen (Gladstone Institutes 201507 VP Corporate Liaison + Ventures) |
Business Development Manager / Strategy Manager |
Gladstone Institutes (Group) |
United States (USA) |
| Freeman, David M. (Cell Signaling Technology 201301 Head of Global Marketing) |
Sales Manager / Marketing Manager |
Cell Signaling Technology (CST) (Group) |
United States (USA) |
| Fregien, Jörg (Life Science Inkubator 201103 Managing Director) |
Managing Director |
Life Science Inkubator GmbH (LSI) |
Germany |
| Frei, Patrik (Venture Valuation 201802 CEO + Founder) |
Chief Executive Officer (CEO) |
Venture Valuation (Group) |
Switzerland |
| Freier, Gottfried W. (Kaye Scholer LLP 200809 Frankfurt/M) |
Attorney / Lawyer |
Arnold & Porter LLP |
Germany |
| Freischem, Barbara (EBE 201609 Executive Director) |
lobbying |
EFPIA (European Federation of Pharmaceutical Industries Associations) |
Belgium |
| Freitag, Chris (Dynacure 201807– CMO before Debioparm + BTG plc + Shire + Roche) |
Chief Medical Officer (CMO) |
Dynacure S.A.S. |
France |
| French, Hayley (Apitope 201810– COO + interim CEO before CBO + General Counsel since 11/10 before Novartis) |
Chief Operating Officer (COO) |
Apitope (Group) |
Belgium |
| Frenkl, Tara (Bayer 202204– Head of Oncology Development at Oncology Strategic Business Unit before GSK + Merck (US)) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Frenzel, Bernd (Biochrom AG 201110 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Freudenberg, Rainer (CMS 201408 Associate at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Frey, Claudia (Cytosurge 202103 Marketing Manager) |
Sales Manager / Marketing Manager |
Cytosurge AG |
Switzerland |
| Frey, Olivier (InSphero 2016– Microphysiological Systems Product Manager before ETHZ) |
Product Manager (personnel) |
InSphero (Group) |
Switzerland |
| Freyberg, Mark-Andre (CytoTools 201111 Managing Director) |
Managing Director |
CytoTools (Group) |
Germany |
| Freyer, Ralf (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
| Fricke, Harald (Apogenix GmbH 200511– CMO + COO before Fresenius Biotech + Baxter + GSK) |
Chief Medical Officer (CMO) |
Apogenix AG |
Germany |
| Frickel, Fritz (Therascope 200307 CEO) |
Chief Executive Officer (CEO) |
Amgen (Group) |
Germany |
| Friebe, Margaret (m2f Investment Ltd 201305 Managing Director) |
Investment Manager |
m2f Investment Ltd. (DE) |
Germany |
| Friebe, Michael (m2f Investment Ltd 201305 Managing Director) |
Investment Manager |
m2f Investment Ltd. (DE) |
Germany |
| Friedemann, Susan (CCS Cell Culture Service 201007 Sales & Communication) |
Sales Manager / Marketing Manager |
Evotec (Group) |
Germany |
| Friedhoff, Paul (Bruker-Quantron GmbH 200609– Managing Director before Quantron GmbH Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
| Friedman, Gary (Novartis 201007 Medical Director – Infectious Disease, Transplantation + Immunology) |
Chief Medical Officer (CMO) |
Novartis (Group) |
Switzerland |
| Friedman, Isaac (Abbott 201203 Head of STARLIMS business) |
President/Director/Head Business Group/Unit/Division |
Abbott (Group) |
Israel |
| Friedman, Michael (AmniSure International 201205 CEO) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
United States (USA) |
| Friedman, Paul A. (Incyte 201401 non-executive Board Member before CEO) |
Board member, non-executive |
Incyte Corporation (Group) |
United States (USA) |
| Friedrich, Alex (Univ Groningen 201203 Prof + Chair Medical Microbiology and Infection Control at UMCG) |
Professor |
University of Groningen (Rijksuniversiteit Groningen) |
Netherlands |
| Friedrich, Benjamin (Temedica 202201 CMO) |
Chief Medical Officer (CMO) |
Temedica GmbH |
Germany |
| Friedrich, Colette (BianoScience GmbH 2010– CFO before Osram Sylvania) |
Chief Financial Officer (CFO) |
BianoScience GmbH |
Germany |
| Friedrich, Eva (SDL 201604 Field Marketing Manager DACH) |
n. a. |
SDL (Group) |
United Kingdom (GB) |
| Friedrich, Glenn A. (Kymab 201511 COO) |
Chief Operating Officer (COO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Friedrichowski, Stefan (HiperScan GmbH 200901 Managing Director Sales) |
Managing Director |
HiperScan GmbH |
Germany |
| Friedritz, Björn (Cyrano Kommunikation 201711 before BlueSens Gas Sensor GmbH 201202) |
Public Relations Manager / Investor Relations Manager |
Cyrano Kommunikation GmbH |
Germany |
| Friese, Andreas (OLS Omni Life Sciences 201901 Head of Sales) |
Sales Manager / Marketing Manager |
Omni Life Science (OLS) (Group) |
Germany |
| Friese, L. |
n. a. |
3i (Group) |
Germany |
| Friese, Manuel (Univ Hamburg 201408 Prof at UKE + Director o INIMS) |
Professor |
University of Hamburg |
Germany |
| Friesen, Robert (Ablynx 201803– CSO before ProQR Therapeutics + Janssen BioTherapeutics + MorphoSys) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
Belgium |
| Frisch, Jürgen (Immatics 200501– CMO before Intercell) |
Chief Medical Officer (CMO) |
Immatics (Group) |
Germany |
| Frischmuth, Thomas (Panatecs 201205– Managing Director + Greenovation 201105 Managing Director + baseclick) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Fritz, Carolyn (Allylix 201411 CEO) |
Chief Executive Officer (CEO) |
Evolva (Group) |
United States (USA) |
| Fritz, Jutta (NanoSphere Biotechnologies 202207 CBO before Blackfield + Kinaxo+ Max Planck Innovation) |
Business Development Manager / Strategy Manager |
|
|
| Fritz, Michaela (Medical Univ Vienna 201510– Vice-Rector Research + Innovation before AIT + LISA + Infineon) |
n. a. |
Medical University of Vienna (MedUni Wien) |
Austria |
| Fritzsche, Steffen (Grünenthal 201611 Senior Director Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Grünenthal (Group) |
Germany |
| Frohnmeyer, Hanns (LBWW Analyst) |
Analyst (Financial / Industry) |
LBBW (Group) |
Germany |
| Fronhoff, Bernd (Axiogenesis 201603 CFO/COO) |
Chief Financial Officer (CFO) |
Evotec (Group) |
Germany |
| Frost, Peter (PeloBiotech GmbH 201202– Managing Director) |
Managing Director |
PeloBiotech GmbH |
Germany |
| Fruchterman, Todd (3M 201306 SVP RnD + CMO at 3M Health Care) |
Chief Medical Officer (CMO) |
3M (Group) |
United States (USA) |
| Fruebis, Joachim (Pfizer 201309– Senior Director before Wyeth + Boehringer + ZymoGenetics + Genset) |
Business Development Manager / Strategy Manager |
Pfizer (Group) |
United States (USA) |
| Fruhstorfer, Peter (Eppendorf 201912– Co-CEO before Head of Business Area Sample Handling) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Früchtl, Norbert (Wulf Group 202111 Managing Director of zwei.7 Beteiligungsmanufaktur GmbH) |
Managing Director |
WULF Group (family of Karsten Wulf / zwei.7) |
Germany |
| Fuchs, Jürgen (LISAvienna 201211 Cluster Manager Biotechnology + Pharma) |
Cluster Manager |
Austria (govt) |
Austria |
| Fuchs, Manfred (OHB-System 1982–200902 CEO + founder) |
Chief Executive Officer (CEO) |
Fuchs (Group) |
Germany |
| Fuchs, Marco R. (OHB-System 200902 Executive Board Director) |
Board member, executive |
Fuchs (Group) |
Germany |
| Fuchs, Markus (Knauer 201411 Sales) |
Sales Manager / Marketing Manager |
Knauer (Group) |
Germany |
| Fuchs, Merle (PramoMolecular GmbH 202204 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
PramoMolecular GmbH |
Germany |
| Fuchs, Michael (Ritter GmbH 200704–) |
Sales Manager / Marketing Manager |
Ritter GmbH |
Germany |
| Fuchs, Patrick (DZ Bank) |
n. a. |
Volks- und Raiffeisenbanken (DE) (Group) |
Germany |
| Fuchs, Thomas (Cimeio Therapeutics 202204 CEO before Genentech/Roche) |
Chief Executive Officer (CEO) |
Cimeio Therapeutics AG |
Switzerland |
| Fuchslueger, Ulf (Vialis AG 201105 CEO) |
Chief Executive Officer (CEO) |
Vialis (Group) |
Switzerland |
| Fudge, Ann |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Fudukidis, Alexander (Alex) (Affimed 202005– Head IR before Synoes Health) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
| Fuenzalida, Fernando (Endress+Hauser 2012–201705 Supervisory Board Member before CFO 1998–2012) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
| Fuenzalida, Gonzalo (Andes Ag 202109 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Andes Ag Inc. |
United States (USA) |
| Fuhge, Peter |
n. a. |
Affimed (Group) |
Germany |
| Fuhr, Günter R. (Fraunhofer 201402 Head of Fraunhofer IBMT) |
Professor |
Fraunhofer (Group) |
Germany |
| Fuhrer, David (Neopharm Group (IL) 201307 CEO + Owner) |
Chief Executive Officer (CEO) |
Neopharm (IL) (Group) |
Israel |
| Fuhrer, Katrin (TOFwerk 202205 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
TOFwerk AG |
Switzerland |
| Fujita, Makoto (Univ Tokyo 201906 Prof at Univ Tokyo + Institute for Molecular Science) |
Professor |
University of Tokyo |
Japan |
| Fukuoka, Takashi (Daiishi Sankyo 201811 Head of Venture Science Laboratories (VSL)) |
Business Development Manager / Strategy Manager |
Daiichi Sankyo (Group) |
Japan |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 20 21 22 ... 81 82 83 
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
